Sector: MedicalAP Pharma, Inc. (NASDAQ: APPA)
Headlines
- A.P. Pharma to Transfer to Nasdaq Capital Market
Oct 28, 2009 06:00 AM | APPA, NDAQ
- A.P. Pharma Announces Private Equity Placement
Oct 20, 2009 06:00 AM | APPA
- A.P. Pharma Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
Sep 21, 2009 06:00 AM | APPA
- A.P. Pharma and Merial Enter into Worldwide Agreement
Sep 15, 2009 06:05 AM | APPA
- Extreme FDA Calendar Trades: 20 Stocks Under $5
Jul 21, 2009 08:52 AM | ADLS, APPA, APPY, ARNA, COV, CRXX
- FDA Extreme Trades: 16 Stocks Under $5
Jun 27, 2009 04:55 PM | ANPI, APPA, CTIC, DDSS, GSK, HEB
- RHEI Begins Final China Trial For Oral Cadidiasis Product
Dec 08, 2008 02:06 PM | APPA, JNJ
- Earnings Preview For Nov 3 - 7 - Earnings Preview
Oct 31, 2008 10:03 PM | ABCO, ABD, ACW, ADES, AEE, AER
- A.P. Pharma Reports Second Quarter 2009 Financial Results
Aug 04, 2009 07:14 AM | APPA
- A.P. Pharma Receives Nasdaq Notice of Non-Compliance; Company to Request Hearing
Jul 20, 2009 06:51 AM | APPA
- A.P. Pharma Announces FDA Acceptance of APF530 New Drug Application for Chemotherapy-Induced Nausea and Vomiting
Jul 20, 2009 06:06 AM | APPA
- A.P. Pharma Receives Extension for Nasdaq Listing Compliance
Jun 03, 2009 06:51 AM | APPA
- A.P. Pharma Presents APF530 Phase 3 Data at Annual Meeting of the American Society of Clinical Oncology
Jun 01, 2009 06:07 AM | APPA
- A.P. Pharma Announces Additional Restructuring Effort
May 29, 2009 06:01 AM | APPA
- A.P. Pharma Submits New Drug Application for APF530 in Chemotherapy-Induced Nausea and Vomiting
May 18, 2009 06:10 AM | APPA
- APF530 Phase 3 Data for Chemotherapy-Induced Nausea and Vomiting to be Presented at American Society of Clinical Oncology 2009 Annual Meeting
May 18, 2009 06:06 AM | APPA
- Tang Capital Partners, LP and Perceptive Life Sciences Master Fund Ltd. Urge the Shareholders of Penwest Pharmaceuticals Co. To Vote for Their Shareholder Proposals
May 15, 2009 10:14 AM | APPA, GENZ, NTII, PPCO, RDEA
- A.P. Pharma Reports First Quarter 2009 Financial Results
May 14, 2009 06:53 AM | APPA
- Form 4 PRENTKI RONALD J For: Jul 08 (10K)
Jul 08, 2009 08:45 PM
- Form 4 ZERBE ROBERT L MD For: May 27 (10K)
May 29, 2009 11:01 PM
- Form 4 GODDARD PAUL For: May 27 (10K)
May 29, 2009 10:50 PM
- Form 4 TURNBULL GREG For: May 27 (10K)
May 29, 2009 10:37 PM
- Form 4 ROSENBLATT TOBY For: May 27 (10K)
May 29, 2009 09:36 PM
- Form 4 Whelan John For: Feb 23 (10K)
Feb 25, 2009 07:57 PM
- Form 3 Whelan John For: Feb 23 (10K)
Feb 25, 2009 07:34 PM
- Form 4 AP PHARMA INC /DE/ For: Jan 16 Filed by: BARR JOHN (10K)
Jan 20, 2009 01:12 PM
- Form 4 TANG KEVIN C For: Dec 31 (10K)
Jan 05, 2009 08:27 PM
- Form 4 TANG KEVIN C For: Dec 18 (10K)
Dec 22, 2008 06:31 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
APPA
|
Compare to S&P
|
| YTD |
88.10 %
|
63.96 %
|
| 4 Weeks |
-3.78 %
|
-4.80 %
|
| 12 Weeks |
-8.09 %
|
-10.37 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -30.00 %
|
|
EPS Growth in Last Year: 35.00 %
|
|
Sales Growth in Last Quarter: 75.00 %
|
|
Sales Growth in Last Quarter: -90.79 %
|
|
